marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Phio Pharmaceuticals Corp. Financial Ratios 2011-2024 | PHIO
Annual Financial Ratios Phio Pharmaceuticals Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.6 | -0.1 | -2.1 | -0.5 | -0.3 | -0.8 | -0.5 | -1.5 | -2.3 | -2.4 | - | - |
P/S |
- | - | - | 4147.8 | 194.0 | 18.2 | 624.6 | 230.1 | 442.9 | 283.5 | 125.8 | - | - |
EPS |
-5.2 | -10.1 | -12.4 | -1.9 | -19.3 | -57.5 | -5.5 | -16.4 | -2.1 | -0.8 | -2.9 | -5.6 | -0.3 |
EV (Enterprise Value) |
-5.46 M | -3.16 M | -19.9 M | 6.57 M | -569 K | -10.6 M | 8.05 M | -5.99 M | 12.2 M | 18.1 M | 48.8 M | 6.3 M | 1.78 M |
EBITDA per Share |
-5.17 | -10 | -12.6 | -1.51 | -19.4 | -56.9 | -226 | -731 | -1.12 K | -2.94 K | -11.2 K | - | - |
EV/EBITDA |
1.5 | -0.5 | 0.3 | 1.7 | -0.6 | 1.0 | -1.0 | -1.3 | -1.9 | 0.4 | - | ||
PEG |
-0.0 | -0.01 | -0.0 | -1.62 | -0.01 | -0.0 | -0.01 | -0.02 | -0.02 | -0.03 | -0.06 | - | - |
P/B |
0.2 | 0.6 | 0.0 | 1.4 | 0.7 | 0.2 | 5.1 | 0.4 | 1.7 | 7.3 | 10.2 | - | - |
P/CF |
-0.1 | -0.5 | -0.1 | -2.1 | -0.5 | -0.3 | -1.0 | -0.6 | -2.0 | -2.6 | -7.9 | - | - |
ROE % |
-140.05 | -105.92 | -60.58 | -67.56 | -154.98 | -54.21 | -679.32 | -82.86 | -114.99 | -320.58 | -423.41 | -331.11 | - |
ROA % |
-115.61 | -89.59 | -52.79 | -55.87 | -110.81 | -48.04 | -303.86 | -67.13 | -91.61 | -95.77 | -140.08 | -230.41 | - |
ROCE % |
-140.03 | -105.76 | -61.60 | -64.93 | -145.92 | -54.23 | -510.97 | -83.05 | -115.15 | -112.36 | -162.88 | -329.41 | - |
Current Ratio |
5.7 | 6.5 | 7.8 | 6.9 | 3.9 | 8.7 | 1.7 | 5.2 | 4.8 | 6.7 | 7.1 | 3.2 | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Phio Pharmaceuticals Corp.
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.54 | -3.62 | -0.47 | - | -10.25 | -13.27 | -3.15 | - | -3.14 | -2.22 | -2.34 | - | -0.28 | -0.2 | -0.32 | - | -0.4 | -0.34 | -1.33 | - | -4.53 | -4.62 | -5.71 | - | -0.34 | -0.46 | -0.9 | - | -1.05 | -1.12 | -2.65 | - | -3.36 | -3.38 | -3.41 | - | -0.38 | -0.5 | -1.32 | - | -0.17 | -0.23 | -0.32 | - | -0.3 | -0.39 | -2.76 | - | -0.56 | -4.13 | -0.04 | - | -0.05 | -0.05 | - |
EBITDA per Share |
- | - | -0.48 | - | - | - | -3.14 | - | -3.09 | - | -2.32 | - | -0.27 | -0.2 | -0.34 | - | -0.39 | -0.33 | -1.32 | - | -4.46 | -4.59 | -5.73 | - | -0.33 | -0.45 | -0.89 | - | -1.03 | -1.11 | -3.44 | - | -3.31 | -3.35 | -3.41 | - | -0.38 | -0.48 | -1.23 | - | -0.12 | -0.14 | -0.18 | - | -0.17 | -0.17 | -2.21 | - | -0.3 | -1.72 | - | - | -0.05 | - | - |
ROE % |
-156.72 | -164.45 | -141.26 | -113.55 | -139.98 | -127.88 | -117.03 | -54.90 | -69.73 | -58.11 | -52.54 | -34.99 | -52.73 | -55.64 | -59.17 | -48.64 | -85.07 | -103.77 | -126.32 | -108.70 | -119.69 | -94.26 | -72.86 | -41.49 | -176.57 | -300.65 | -423.80 | -570.10 | -590.48 | -475.78 | -359.01 | -61.31 | -89.38 | -97.08 | -101.07 | -85.57 | -165.93 | -218.22 | -266.93 | -236.65 | -278.31 | -239.61 | -206.21 | -372.66 | -344.51 | -274.70 | -14.47 | 469.25 | 901.44 | 1305.49 | 1517.14 | - | 432.20 | 432.20 | - |
ROA % |
-121.42 | -124.58 | -110.45 | -86.98 | -109.63 | -103.13 | -94.96 | -47.13 | -60.52 | -51.27 | -47.19 | -31.94 | -46.61 | -47.89 | -50.03 | -40.23 | -66.28 | -77.66 | -92.35 | -77.72 | -87.47 | -71.16 | -58.25 | -36.76 | -97.18 | -147.86 | -196.80 | -255.00 | -271.51 | -227.61 | -182.77 | -49.68 | -72.04 | -77.90 | -80.80 | -68.17 | -92.18 | -93.82 | -96.24 | -70.69 | -84.48 | -74.25 | -65.55 | -123.29 | -152.69 | -168.30 | -385.51 | -490.06 | -639.82 | -760.19 | -679.62 | - | -149.76 | -149.76 | - |
ROCE % |
-160.78 | -167.12 | -142.11 | -113.47 | -139.87 | -127.78 | -116.89 | -54.80 | -69.61 | -58.02 | -52.50 | -35.70 | -53.42 | -56.32 | -59.84 | -48.64 | -85.40 | -104.44 | -127.44 | -109.92 | -120.90 | -95.13 | -73.30 | -41.46 | -176.54 | -300.63 | -423.80 | -658.54 | -678.95 | -564.29 | -447.54 | -61.50 | -89.67 | -97.42 | -101.37 | -85.66 | -166.13 | -218.44 | -267.71 | -237.52 | -279.43 | -240.86 | -207.00 | -372.93 | -343.88 | -272.94 | -101.96 | 192.88 | 562.04 | 902.17 | 770.95 | - | 369.17 | - | - |
Current Ratio |
- | - | - | - | 4.1 | 5.1 | 4.0 | 6.5 | 7.0 | 6.4 | 8.2 | 7.8 | 10.4 | 11.3 | 13.8 | 5.8 | 5.8 | 5.8 | 5.8 | 3.5 | 3.5 | 3.5 | 3.5 | 8.8 | 8.8 | 8.8 | 8.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.2 | 11.1 | 9.9 | 7.6 | 3.3 | 3.3 | 3.3 | 3.3 | 0.7 | 0.7 | 0.7 | 0.7 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency